Telomeres

The distinction to keep

A telomere-related endpoint deserves assay checks, population context, and a careful distinction between cell-level measurements and a person’s health. The current Indian trial is indexed here as a biomarker study, not proof of longer life.

Questions for a useful brief

• Which cell population and assay were used?
• Could cell composition affect the measurement?
• Is the change linked to a prespecified functional outcome?

Build a decision—not a slogan

Write down the actual model and endpoint before deciding what the result implies. Then name the observation that would change your interpretation. The linked records below retain their original experimental setting and source-access limits.